A Phase 3 Multicenter Randomized Parallel-Design Open-Label Trial to Evaluate the Efficacy and Safety of Ly3209590 Compared With Insulin Degludec in Participants With Type 2 Diabetes Currently Treated With Basal Insulin (Qwint-3)
ClinicalTrials.gov NCT05275400
Research payments
$5,544,909
Through program year 2023, $5,544,909 in research payments was reported against A Phase 3 Multicenter Randomized Parallel-Design Open-Label Trial to Evaluate the Efficacy and Safety of Ly3209590 Compared With Insulin Degludec in Participants With Type 2 Diabetes Currently Treated With Basal Insulin (Qwint-3), across 102 payments.
- Paid by (largest first)
- Eli Lilly and Company; Eli Lilly Export S.A. Puerto Rico Branch
- ClinicalTrials.gov
- NCT05275400
By program year
1 row| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2023 | Research | $5,544,909 | 102 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
10 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Frances Broyles Renton, WA Named on 4 payments
- Lisa Connery Norman, OK Named on 3 payments
- Stanley Hsia Orange, CA Named on 3 payments
- Richard Bergenstal St Louis Park, MN Named on 3 payments
- Timothy Bailey Escondido, CA Named on 3 payments
- Ralph Duda Springfield, MO Named on 2 payments
- Carl Vance Idaho Falls, ID Named on 2 payments
- Gregorio Cortes-Maisonet San Juan, PR Named on 2 payments
- Harold Bays Louisville, KY Named on 2 payments
- Martha Gomez San Juan, PR Named on 2 payments
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.